Aurinia Pharmaceuticals Inc.
Aurinia Pharmaceuticals Inc. (AUPH) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 156 transactions totaling $50.9M, demonstrating a bearish sentiment with -$21.9M in net insider flow. The most recent transaction on Feb 20, 2026 involved a transaction of 34,638 shares valued at $498.8K.
AUPH Insider Activity Summary
Who Is Buying AUPH Stock?
No significant insider buying has been recorded for AUPH in the recent period.
Who Is Selling AUPH Stock?
No significant insider selling has been recorded for AUPH in the recent period.
Is Aurinia Pharmaceuticals Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AUPH is bearish with an Insider Alignment Score of 28/100 and a net flow of -$21.9M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
AUPH Frequently Asked Questions
Understanding AUPH Insider Activity
Insider trading at Aurinia Pharmaceuticals Inc. (AUPH) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading AUPH stock, having executed 156 transactions in the past 90 days. The most active insider is Michael Robert Martin (Executive), who has made 33 transactions totaling $15.3M.
Related Tools
Track Aurinia Pharmaceuticals Inc. Insider Activity
Get notified when executives and directors at AUPH file new Form 4 transactions